Sanjay Chandru Keswani
CIK 1818524 · Chief Medical Officer · last filed 2026-06-04
Sanjay Chandru Keswani is a Chief Medical Officer who has filed 6 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for NBIX, was dated Jun 4, 2026. Across all open-market trades the lifetime net is −$120.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $311.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$311.3K
2
6
-$120.5K
Holdings By Company
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | NBIX | Mixed | +1,479 | -$268.3K | EDGAR |
| 2026-02-17 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2025-06-04 | NBIX | Grant (A) | — | $0 | EDGAR |
| 2022-02-15 | ANNX | Grant (A) | +12,500 | $0 | EDGAR |
| 2021-03-26 | ANNX | Mixed | — | -$90.6K | EDGAR |
| 2021-03-01 | ANNX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.